Literature DB >> 16511688

[Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies].

J R Siewert1, F Lordick, K Ott, B L D M Brücher, R Rosenberg.   

Abstract

Locoregional recurrence is a relevant problem in surgical oncology. Intraluminal local relapse only occurs when the primary resection is carried through with inappropriate safety margins. If possible, a second surgical resection with wider margins is the treatment of choice. When the primary resection was appropriately done, extraluminal relapse in the original tumor bed indicates the primary tumor was already in an advanced stage. The indication for a second resection must be considered carefully. A realistic prospect of long-term tumor control exists only when the second resection yields tumor-free margins and is combined with chemo- and radiotherapy. There is usually no curative treatment option for recurrences in the draining lymph node region, the so-called fourth dimension.

Entities:  

Mesh:

Year:  2006        PMID: 16511688     DOI: 10.1007/s00104-006-1163-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  32 in total

Review 1.  [Posterior pelvic exenteration in locoregional recurrence of rectal carcinoma--indications, technique and outcome].

Authors:  T Lehnert; M Golling
Journal:  Chirurg       Date:  2001-12       Impact factor: 0.955

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

4.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

Authors:  W A Weber; K Ott; K Becker; H J Dittler; H Helmberger; N E Avril; G Meisetschläger; R Busch; J R Siewert; M Schwaiger; U Fink
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

5.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.

Authors:  Pedro Luna-Pérez; Efraín Bustos-Cholico; Isabel Alvarado; Antonio Maffuz; Saúl Rodríguez-Ramírez; Marcos Gutiérrez de la Barrera; Sonia Labastida
Journal:  J Surg Oncol       Date:  2005-04-01       Impact factor: 3.454

7.  Surgical treatment of locally recurrent rectal carcinoma.

Authors:  F Bozzetti; L Bertario; C Rossetti; L Gennari; S Andreola; D Baratti; A Gronchi
Journal:  Dis Colon Rectum       Date:  1997-12       Impact factor: 4.585

8.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

9.  Pancreaticoduodenectomy for advanced gastric cancer.

Authors:  Makoto Saka; Satvinder S Mudan; Hitoshi Katai; Takeshi Sano; Mitsuru Sasako; Keiichi Maruyama
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 10.  Position of positron emission tomography and other imaging diagnostic modalities in esophageal cancer.

Authors:  P Flamen; T Lerut; K Haustermans; E Van Cutsem; L Mortelmans
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

View more
  4 in total

1.  [Response prediction--early response evaluation. Consequences for surgical oncology].

Authors:  J R Siewert; F Lordick
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

Review 2.  Gastric cancer: surgery in 2011.

Authors:  Katja Ott; Florian Lordick; Susanne Blank; Markus Büchler
Journal:  Langenbecks Arch Surg       Date:  2011-01-14       Impact factor: 3.445

Review 3.  [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint].

Authors:  K Ott; F Lordick
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

Review 4.  Peritoneal carcinomatosis.

Authors:  Federico Coccolini; Federico Gheza; Marco Lotti; Salvatore Virzì; Domenico Iusco; Claudio Ghermandi; Rita Melotti; Gianluca Baiocchi; Stefano Maria Giulini; Luca Ansaloni; Fausto Catena
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.